Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?
Status:
Completed
Trial end date:
2018-05-04
Target enrollment:
Participant gender:
Summary
Our study investigated the effect of using a known drug used in intermittent claudication
(named pentoxifylline) as an adjuvant to erythropoietin stimulating agents to improve anemia
of hemodialysis patients.